Fighting Lymphoma Knows No Borders

This month, the journey to wellness for one Hodgkin’s patient will illustrate just how small our world has become in the information age, and prove that the fight against lymphoma knows no borders.



Lori Montgomery, an instructor at Pratt Community College (PCC) in Kansas, will undergo a life-saving allogeneic stem cell transplant at the University of Nebraska Medical Center on January 22. Yet the stem cells are not coming from family, friends, or colleagues, as none of the many people tested were a match.



Rather, thanks to the Bone Marrow Foundation, a perfect match was found thousands of miles away, in an unnamed donor from Germany.



According to an article in the Pratt Tribune the procedure will keep Mrs. Montgomery in Nebraska for over three months, but once again, distance and borders will be overcome despite her lymphoma, as she will continue to teach classes at PCC via webcam.



Our best wishes go out to Mrs. Montgomery, and to the unnamed individual living in Germany whose decision to donate stem cells will make the difference between life and death.



We all stand to make that remarkable difference in the life of another person. Check out the National Marrow Donor Program at www.marrow.org or the Bone Marrow Foundation at www.bonemarrow.org to see if you’ve got what it takes to join the global registry.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap